Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

StrideBio

3 Disclosed Funding Rounds $97,200,000

0 Participating Investments


Therapeutics, Health Care, Biotechnology, Information Technology

StrideBio, Inc. is a gene therapy company

Durham, North Carolina, United States, North America (US)

Organizations in Durham in Therapeutics,
Organizations in Durham in Health Care,
Organizations in Durham in Biotechnology,
Organizations in Durham in Information Technology,
Organizations in North Carolina in Therapeutics,
Organizations in North Carolina in Health Care,
Organizations in North Carolina in Biotechnology,
Organizations in North Carolina in Information Technology,
Organizations in United States in Therapeutics,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in United States in Information Technology,
Organizations in North America in Therapeutics,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology,
Organizations in North America in Information Technology

Investors in Durham in Therapeutics,
Investors in Durham in Health Care,
Investors in Durham in Biotechnology,
Investors in Durham in Information Technology,
Investors in North Carolina in Therapeutics,
Investors in North Carolina in Health Care,
Investors in North Carolina in Biotechnology,
Investors in North Carolina in Information Technology,
Investors in United States in Therapeutics,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in United States in Information Technology,
Investors in North America in Therapeutics,
Investors in North America in Health Care,
Investors in North America in Biotechnology,
Investors in North America in Information Technology

Southern US (0 Investors) (0 Startups), Research Triangle (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups)

Founded date 01, 2015

Founders Mavis Agbandje, Aravind Asokan, Patrick Ritschel

Operating Status Active

Funding Stage Early Stage Venture

Last Funding Type Series B

Company Type For Profit


LinkedIN Link

Wikipedia Link

StrideBio, LLC is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies and therapeutics for rare diseases. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies and improving gene transfer efficiency in patients. This powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities for a wide range of diseases, including rare genetic diseases. StrideBio is headquartered in Durham, NC.

Date Round Raised Lead
March, 16, 2021 Series B $81,500,000 Novo Holdings, Northpond Ventures
June, 13, 2018 Series A $15,700,000 Hatteras Venture Partners
June, 01, 2017 Seed Undisclosed Hatteras Venture Partners

StrideBio Investors (16)

Investor Lead? Round Participating Raise Date Partners
UCB Ventures No Series B $81,500,000 March, 16, 2021 -------
CaaS Capital Management No Series B $81,500,000 March, 16, 2021 -------
Octagon Capital Advisors No Series B $81,500,000 March, 16, 2021 -------
UF Innovate Ventures No Series B $81,500,000 March, 16, 2021 -------
Takeda Ventures No Series B $81,500,000 March, 16, 2021 -------
Sarepta Therapeutics No Series B $81,500,000 March, 16, 2021 -------
Pontifax No Series B $81,500,000 March, 16, 2021 -------
Novo Holdings Yes Series B $81,500,000 March, 16, 2021 -------
Northpond Ventures Yes Series B $81,500,000 March, 16, 2021 -------
Hatteras Venture Partners No Series B $81,500,000 March, 16, 2021 -------
Alexandria Venture Investments No Series B $81,500,000 March, 16, 2021 -------
Hatteras Venture Partners Yes Series A $15,700,000 June, 13, 2018 -------
Takeda Ventures No Series A $15,700,000 June, 13, 2018 -------
UCB Pharma No Series A $15,700,000 June, 13, 2018 -------
Alexandria Venture Investments No Series A $15,700,000 June, 13, 2018 -------
Hatteras Venture Partners Yes Seed Undisclosed June, 01, 2017 -------